The Prognosis Value of Lymphatic Vessel Invasion in pN0 Gastric Cancer Patients with Insufficient Examined Lymph Nodes.
LVI
Node-negative
Prognostic
Stage migration
Stomach
Journal
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: United States
ID NLM: 9706084
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
05
08
2018
accepted:
29
12
2018
pubmed:
24
1
2019
medline:
2
3
2021
entrez:
24
1
2019
Statut:
ppublish
Résumé
To investigate the prognosis value of lymphatic vessel invasion (LVI) in pN0 gastric cancer patients with insufficient examined lymph nodes (ELNs). Clinicopathologic and prognostic data of pN0 gastric cancer patients with insufficient ELNs who underwent radical surgery in our institution were retrospectively studied. Firstly, we confirmed that less than 16 but not less than 30 ELNs were insufficient ELNs in the present study. Of the 350 pN0 patients with < 16 ELNs, 64 patients (18.29%) had LVI. The overall survival (OS) of patients with LVI was significantly poorer than those without LVI. Multivariate analysis suggested that LVI was one of the independent factors predicting prognosis of pN0 patients with < 16 ELNs. Further analyses suggested that there were similar prognoses between pN0 patients with < 16 ELNs who had LVI and pN1 patients, and between pN0 patients with < 16 ELNs who had no LVI and pN0 patients with ≥ 16 ELNs, respectively. Therefore, we proposed a novel pN classification, in which LVI-positive pN0 gastric cancer with < 16 ELNs was classified as pN1 disease. Two-step multivariate analysis demonstrated that the novel pN classification was more suitable for prognostic assessment than the original one. LVI is a powerful and independent prognostic factor for pN0 gastric cancer patients with < 16 ELNs, and node-negative gastric cancer with < 16 ELNs which had LVI should be considered as node-positive disease. LVI is an effective indicator identifying patients stage migration happens to in pN0 patients with < 16 ELNs.
Identifiants
pubmed: 30671803
doi: 10.1007/s11605-018-04101-z
pii: 10.1007/s11605-018-04101-z
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
299-306Références
Cancer. 2005 Feb 1;103(3):492-500
pubmed: 15612028
Virchows Arch. 2009 Feb;454(2):143-51
pubmed: 19104832
Ann N Y Acad Sci. 2008;1131:225-34
pubmed: 18519975
J Gastrointest Surg. 2011 Sep;15(9):1526-31
pubmed: 21717282
Ann Surg. 1998 Oct;228(4):449-61
pubmed: 9790335
Am Surg. 1998 Jul;64(7):680-5
pubmed: 9655282
Ann Surg Oncol. 2016 Jan;23(1):142-8
pubmed: 25986866
N Engl J Med. 1985 Jun 20;312(25):1604-8
pubmed: 4000199
Ann Oncol. 2009 May;20(5):897-905
pubmed: 19179553
BMC Cancer. 2014 Sep 18;14:676
pubmed: 25234410
Lancet. 2003 Jul 26;362(9380):305-15
pubmed: 12892963
Cancer. 2010 Jun 1;116(11):2571-80
pubmed: 20336791
J Surg Res. 2014 Dec;192(2):494-502
pubmed: 25033702
J Gastroenterol Hepatol. 2009 Sep;24(9):1527-33
pubmed: 19383080
Thorac Cardiovasc Surg. 2014 Sep;62(6):521-4
pubmed: 24905019
Clin Exp Metastasis. 2010 Mar;27(3):123-32
pubmed: 20195706
J Clin Oncol. 2005 Oct 1;23(28):7114-24
pubmed: 16192595
Cancer. 2012 Oct 1;118(19):4687-93
pubmed: 22415925
Am J Transl Res. 2015 Jan 15;7(1):120-7
pubmed: 25755834
Ann Surg Oncol. 2013 Nov;20(12):3927-34
pubmed: 23892524
Cancer. 1995 Jan 1;75(1):4-10
pubmed: 7804975
Br J Surg. 2001 Oct;88(10):1408-12
pubmed: 11578301